877402-55-6

Usage

Uses

Used in Pharmaceutical Research:
1-([1,2,4]TRIAZOLO[1,5-F]PYRIMIDIN-5-YL)HYDRAZINE is used as a precursor in the synthesis of other organic compounds, particularly for the development of new drugs. Its unique structure and properties make it a promising candidate for creating novel pharmaceuticals.
Used in Chemical Research:
In the chemical research industry, 1-([1,2,4]TRIAZOLO[1,5-F]PYRIMIDIN-5-YL)HYDRAZINE is used as a building block for the creation of new molecules and materials. Its triazolopyrimidine structure and hydrazine functional group offer opportunities for further exploration and innovation in chemical synthesis.
Further research and experimentation are essential to fully comprehend and exploit the potential of 1-([1,2,4]TRIAZOLO[1,5-F]PYRIMIDIN-5-YL)HYDRAZINE in scientific and industrial applications.

Upstream product

• 76044-36-5 5-chloro-s-triazolo<1,5-c>pyrimidine 

Downstream Products

• 877403-12-8 tert-butyl [(1R)-3-oxo-3-(2-[1,2,4]triazolo[1,5-c]pyrimidin-5-ylhydrazino)-1-(2,4,5-trifluorobenzyl)propyl]carbamate 

Relevant academic research and scientific papers

FUSED TRIAZOLE DERIVATIVES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES

The present invention is directed to novel fused triazole derivatives which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DPP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.